Cord Blood Stem Cells Market
Cord Blood Stem Cells Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Cord Blood Stem Cells Market Size and Growth
The Cord Blood Stem Cells market is expanding due to increased awareness of their therapeutic potential and advancements in collection technologies. The market is projected to reach approximately $4.5 billion by 2026, driven by rising demand for regenerative medicine and a growing number of public and private cord blood banks globally.
Companies Covered
(Covid 19 Impact Covered)
◍ Advanced Cell Technology
◍ California Stem Cell
◍ Cytori Therapeutics
◍ Mesoblast Limited
◍ Opexa Therapeutics Inc.
◍ Athersys Inc.
◍ Geron Corporation
◍ Neostem Inc.
◍ CBR Systems, Inc.
◍ Cordlife
◍ Cryo-Cell
◍ Cryo-Save AG (A Group of Esperite)
◍ Lifecell
◍ Stemcyte
◍ Viacord
◍ Smart Cells International Ltd.
◍ Cryoviva India
The cord blood stem cells market features firms like CBR Systems, Cryo-Cell, and China Cord Blood Corporation, which focus on collection, banking, and therapeutic applications. Companies drive growth through advancements in regenerative medicine and partnerships. Sales revenues include: - China Cord Blood Corporation: ~$105 million - CBR Systems: Estimates of over $1 billion.
◍ Cordvida
Request Sample Report
Market Segmentation
By Application
◍ Autoimmune Diseases
◍ Immunodeficiencies
◍ Malignancies,Caners
◍ Solid Tumors
◍ Others
By Product
◍ Allogeneic Stem Cell
◍ Autologous Stem Cell
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
